Tradestie Institutional Equity Comparison Engine
HOMZ vs NURE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NURE Overall Edge
NURE Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuveen Short-Term REIT ETF (NURE) driven by superior Momentum & Technical while HOMZ counters with relative strength in Options & Structure. Fundamentally, HOMZ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NURE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HOMZ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against NURE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
HOMZ N/M vs NURE N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
NURE
1Y -4.7% vs +16.7% ยท 52W Pos 29% vs 86%
Options & Structure Winner
HOMZ
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
HOMZ
NYSE Arca
Hoya Capital Housing ETF
Institutional Equity
$42.72
-0.54% 1D
Market Cap
N/A
1M Return
+4.55%
1Y Return
-4.72%
Forward P/E
N/M
Unified AI Score
42.8 / 100
HOLD
Tech 46.0
Fund 49.0
Flow 50.0
Mom 50.0
NURE
Cboe BZX
Nuveen Short-Term REIT ETF
Institutional Equity
$32.53
+0.42% 1D
Market Cap
N/A
1M Return
+6.38%
1Y Return
+16.73%
Forward P/E
N/M
Unified AI Score
39.5 / 100
SELL
Tech 29.0
Fund 33.0
Flow 50.0
Mom 11.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HOMZ -4.72%
NURE +16.73%
Spread: +21.24 pp (NURE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HOMZ TTM Op. Margin: N/A
NURE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HOMZ vs NURE. Trailing 12-month operating profitability (HOMZ N/A vs NURE N/A) and valuation multiples (HOMZ N/M vs NURE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HOMZ | NURE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 29% ($40โ$50) | 86% ($27โ$33) | Stronger Trend | NURE |
| Beta / 30D Volatility Risk Regime | 0.65ฮฒ ยท 33% Vol | 0.26ฮฒ ยท 18% Vol | Lower Realized Risk | NURE |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 39.5 / 100 (SELL) | Higher Composite | HOMZ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HOMZ vs NURE Buy Guide
HOMZ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
NURE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HOMZ nor NURE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.